Delivery Order SPE2DB25D3020-SPE2DB25FWHBJ
Award Date
4/21/25
Potential Completion Date
5/12/25
Potential Value
$6.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $6,370.00, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order for the supply of 4,567,874,470 units of the prescription medication BRUKINSA 80 MG CAPSULE 120S. The contract has an ultimate completion date of May 1, 2025 and is a firm fixed-price, non-set-aside arrangement. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,370.00 firm fixed-price delivery order is for the supply of 4,567,986,180 units of the medication BRUKINSA 80 MG CAPSULE 120S. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,242.15, is for the delivery of the drug BRUKINSA 80 MG CAPSULE 120S. This is a firm fixed-price delivery order contract with a completion date of December 5, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award, valued at $12,740.00, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BRUKINSA 80 MG CAPSULE 120S, a pharmaceutical product, over a period ending on May 9, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug...
This federal contract award, valued at $6,370.00, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BRUKINSA 80 MG CAPSULE 120S, a pharmaceutical product, with a completion date of February 18, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,370.00, is a Delivery Order for the supply of 4567720736 BRUKINSA 80 MG CAPSULE 120S. It is a Firm Fixed Price contract with an ultimate completion date of April 17, 2025. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of medical products, including BRUKINSA 80 MG CAPSULE 120S. The award, with a ceiling value of $6,370.00, is a delivery order contract with a firm fixed price. The contract has an ultimate completion date of April 22, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award, valued at $12,740.00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BRUKINSA 80 MG CAPSULE 120S, a prescription medication, to support military healthcare programs. The award is structured as a Firm Fixed Price Delivery Order, without any set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract...
This federal contract award, valued at $6,370.00, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BRUKINSA 80 MG CAPSULE 120S, a prescription medication. This is a Firm Fixed Price delivery order contract, with a completion date of March 24, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,564,861 units of the pharmaceutical product BRUKINSA 80 MG CAPSULE 120S. The contract has a ceiling value of $7,242.15 and an ultimate completion date of July 2, 2024. The contract was awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA), which is a major acquisition and logistics agency supporting the U.S. Department of Defense. Amerisourcebergen, a large...